FSI Régions backs Axonal OBO
FSI Régions has taken a minority stake in the owner buyout of French clinical research business Axonal.
The group's founders and managers reinvested in the transaction. BNP and Crédit Agricole provided a debt package to finance the buyout.
FSI Régions invested via its €140m FCPR AED fund. The vehicle invests up to €4m per transaction and has so far made an average contribution of €1.4m across 48 deals.
The new capital structure will allow Axonal to pursue bolt-on opportunities in order to drive growth.
Company
Founded in 1989, Axonal provides project support to pharmaceutical companies, medical device manufacturers and not-for-profit sponsors in the management of clinical trials, pharmaco-epidemiological studies, surveys and observational studies.
The Nanterre-based business posted a €3.9m turnover and €90,000 EBITDA in 2010.
People
Cyril Chaumien and Serge Mesguich led the deal for FSI Régions. Denis Comet and Jean-Pierre Meunier are co-founders of Axonal.
Advisers
Equity – ACA François Mahe (Financial due diligence).
Management – 3S Finance (Corporate finance); Curtis (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








